Pages that link to "Q70281554"

The following pages link to Economic and policy analysis of university-based drug "detailing" (Q70281554):

Displaying 48 items.

• Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis (Q21254588) (← links)
• Printed educational materials: effects on professional practice and healthcare outcomes (Q24198184) (← links)
• Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns (Q24234308) (← links)
• Printed educational materials: effects on professional practice and health care outcomes (Q24242164) (← links)
• Educational outreach visits: effects on professional practice and health care outcomes (Q24243120) (← links)
• Prescription data as a tool in pharmacotherapy audit (I). General considerations (Q30578487) (← links)
• Designing a multifaceted quality improvement intervention in primary care in a country where general practice is seeking recognition: the case of Cyprus (Q33364270) (← links)
• The cost effectiveness of drug utilisation review in an outpatient setting (Q33560165) (← links)
• Economic impact of cost-containment strategies in third party programmes in the US. Part II. (Q33560199) (← links)
• Improving the quality and cost-effectiveness of prescribing (Q33560208) (← links)
• Pharmacoeconomic consequences of measurement and modification of hospital drug use. (Q33560292) (← links)
• Impact of drug usage review on drug utilisation (Q33560302) (← links)
• A review of limited lists and formularies: are they cost-effective? (Q33560385) (← links)
• Drug utilisation studies as tools in health economics (Q33560623) (← links)
• Economic incentives and disincentives for efficient prescribing (Q33568916) (← links)
• Strategies to improve the cost effectiveness of general practitioner prescribing. An international perspective (Q33576650) (← links)
• Changing preventive practice: a controlled trial on the effects of outreach visits to organise prevention of cardiovascular disease. (Q33692360) (← links)
• Changing prescribing in the light of tolerability concerns: how is this best achieved? (Q33733013) (← links)
• Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people (Q33955707) (← links)
• Promoting rational prescribing: an international perspective (Q34346896) (← links)
• The influence of an academic representative on prescribing by general practitioners (Q34402563) (← links)
• Implementing guidelines and innovations in general practice: which interventions are effective? (Q34469242) (← links)
• Postgraduate education in clinical pharmacology and therapeutics (Q35803043) (← links)
• Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer). (Q36055023) (← links)
• A brief overview of academic detailing in Canada: Another role for pharmacists (Q36595853) (← links)
• How can we increase translation of research into practice? Types of evidence needed (Q36675475) (← links)
• Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study (Q37450586) (← links)
• Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs. (Q39076017) (← links)
• Pharmacists as agents of change for rational drug therapy. (Q40433597) (← links)
• Polypharmacy in the aged. Practical solutions (Q40696800) (← links)
• Drug prices and third party payment: do they influence medication selection? (Q41039285) (← links)
• Cost-effective prescribing in elderly people (Q41117374) (← links)
• Drug Therapy: The Impact of Managed Care (Q41740941) (← links)
• Reflections on a month in the life of the Ontario Drug Benefit Plan (Q42384245) (← links)
• Computer-focused modification of physician prescribing behavior (Q43052569) (← links)
• Why are we still poisoning the elderly so often? (Q43224834) (← links)
• Rational antibiotic use and academic staff (Q44235435) (← links)
• Changing Prescribing Behavior in the United States: Moving Upstream in Opioid Prescription Education (Q47743586) (← links)
• Clinical and economic evaluation of benzodiazepines: a value analysis (Q48882798) (← links)
• Principles and Uses of Academic Detailing to Improve the Management of Psychiatric Disorders (Q51993730) (← links)
• Characteristics of recipients of free prescription drug samples: a nationally representative analysis (Q57991904) (← links)
• Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. (Q64897831) (← links)
• Pharmacist-physician co-operation at a regional level (Q72358769) (← links)
• Evaluation of an intervention to change benzodiazepine-prescribing behavior in a prepaid group practice setting (Q72668088) (← links)
• [Factors conditioning prescription in primary care] (Q73541860) (← links)
• Improving the Appropriateness of Physician Prescribing (Q74572244) (← links)
• After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics (Q77098853) (← links)
• Cost-effectiveness of strategies to market and train primary health care physicians in brief intervention techniques for hazardous alcohol use (Q77162609) (← links)